"Source Healthcare focuses on resolving pain, restoring function, and avoiding surgery through precision diagnosis and targeted treatments. We provide minimally invasive and conservative care options that help clients avoid spine and joint surgery in order to return to normal activities. Contact us today to book a consultation."

During the past decade, Source Healthcare conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Source Healthcare" #1 sponsor was "VIVEX Biologics, Inc." with 3 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Nature Cell Co. Ltd." with 2 trials sponsored, "Xalud Therapeutics, Inc." with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Source Healthcare" #1 collaborator was "MCRA" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "KCRN Research, LLC" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Talosix" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Source Healthcare" are "Degenerative Disc Disease" (4 trials), "Lumbar Spinal Stenosis" (3 trials), "Osteoarthritis, Knee" (3 trials), "Low Back Pain" (2 trials) and "Back Pain" (1 trials). Many other conditions were trialed in "Source Healthcare" in a lesser frequency.

Most popular intervention types in "Source Healthcare" are "Drug" (10 trials), "Device" (5 trials), "Biological" (4 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "JointStem" (2 trials), "VIA Disc NP" (2 trials), "XT-150" (2 trials) and "Active Allograft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Source Healthcare" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Source Healthcare". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Source Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Source Healthcare, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".